AdvanCell Isotopes Pty Ltd of SYDNEY NSW, C3, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-28. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Anthony Aiudi | Director | Cambridge, MA |
| Kevin Cameron | Director | Cambridge, MA |
| William Ferris | Director | Sydney NSW, C3 |
| Adrian Paterson | Director | Sydney NSW, C3 |
| Simon Puttick | Director | Sydney NSW, C3 |
| Andrew Adamovich | Executive Officer | Cambridge, MA |
| Simon Puttick | Executive Officer | Sydney NSW, C3 |
| Michael Tung | Executive Officer | San Francisco, CA |